OpinionPARP inhibitors: New developments in ovarian cancer treatmentAuthor:Emma C. Rossi, MDPublish date: June 5, 2017Maturing data from ongoing trials will likely expand the opportunity to use PARP inhibitors for the treatment of ovarian cancer.Read More
OpinionOptimizing surveillance for gynecologic cancersAuthor:Emma C. Rossi, MDPublish date: May 3, 2017High-quality surveillance care requires vigilance in the detection of recurrence, but also in the avoidance of unnecessary, costly, and inaccurate ...Read More
ArticleOvarian cancer screening updateAuthor:Emma C. Rossi, MDPublish date: February 3, 2017The average lifetime risk of developing ovarian cancer is low, approximately 1 in 70. Even a clinical test with 100% sensitivity and 99% specificit...Read More
NewsSentinel lymph node technique in endometrial cancer, Part 2Author:Emma C. Rossi, MDPublish date: October 3, 2016The sentinel lymph node technique strikes a balance between the risks and benefits of lymph node evaluation in endometrial cancer.Read More
